Pharmaceutical marketing and product distribution of tablets and capsules.
Annual revenue $64,409 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Wiesel Pharmaceutical

Wiesel Pharmaceutical is a company. Wiesel Pharmaceutical offers products and services including Hepta Gold Tab and Bitazn Capsule.

Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $64.41 K (USD)
    38.98
    as on Mar 31, 2022
  • Net Profit
    $3.63 K (USD)
    -6.54
    as on Mar 31, 2022
  • EBITDA
    -$2.26 K (USD)
    -146.64
    as on Mar 31, 2022
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Wiesel Pharmaceutical

Wiesel Pharmaceutical offers a comprehensive portfolio of products and services, including Hepta Gold Tab and Bitazn Capsule.

Product name locked
Category locked
Primary

Tablets are marketed for medical applications

Product name locked
Category locked
Locked

Capsules are distributed for pharmaceutical use

Funding Insights of Wiesel Pharmaceutical

Premium access

Detailed funding history for Wiesel Pharmaceutical

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Wiesel Pharmaceutical

Investments
Premium access

Investment portfolio details for Wiesel Pharmaceutical

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Wiesel Pharmaceutical

Premium access

Detailed financials for Wiesel Pharmaceutical

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Wiesel Pharmaceutical Comparisons

Wiesel Pharmaceutical Primary company
Description
Pharmaceutical marketing and product distribution of tablets...
Location
-
Founded Year
-
Annual Revenue
$64.41 K (USD)
Net Profit
$3.63 K (USD)
EBITDA
-$2.26 K (USD)
Employees
Not available
Premium access

Peer comparison for Wiesel Pharmaceutical

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Wiesel Pharmaceutical

Premium access

Detailed competitors of Wiesel Pharmaceutical

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Wiesel Pharmaceutical

Premium access

Complete news archive for Wiesel Pharmaceutical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Wiesel Pharmaceutical

Annual revenue of Wiesel Pharmaceutical is $64.41K as on Mar 31, 2022.

Wiesel Pharmaceutical Private Limited is identified as a company engaged in pharmaceutical marketing, where products like Hepta Gold Tab, Bitazn Capsule, and Wielcored Tab are offered for distribution. Its operations are centered on promoting these items in the healthcare sector, ensuring they are made available through established channels. The entity is structured as a private limited company, with a focus on handling medicinal tablets and capsules that are utilized in various medical contexts. Activities are conducted in a manner that supports industry standards without promotional intent.

Wiesel Pharmaceutical offers Hepta Gold Tab and Bitazn Capsule.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available